Skip to main content

Table 2 Utility scores

From: Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses

Status Utility value Comments
Remission 0.799 [28]  
Relapse 0.670 [28]  
Acute EPS (extra-pyramidal symptoms) 0.7095 Calculated by multiplying remission utility by expected decrement in utilities estimated in the NICE guidance [18] (0.888 for acute EPS and 0.959 for weight gain)
Weight gain 0.7662  
Diabetes Mellitus (controlled) 0.760 [29]  
Diabetes Mellitus complications Disutility value [30]  
Amputation -0.109  
Fatal myocardial infarction 1.000  
Heart failure -0,108  
Ischaemic heart disease -0.132  
Non-fatal myocardial infarction -0.129  
Non-fatal Stroke -0.181